Nordic Group B.V. Shares Insights on LACRIFILL® Canalicular Gel for Dry Eye Treatment at AAO 2025 Nordic Pharma, a subsidiary of Nordic Group B.V., details the promising results of LACRIFILL® at the American Academy of Ophthalmology 2025 meeting.

Nordic Group B.V. Shares Insights on LACRIFILL® Canalicular Gel for Dry Eye Treatment at AAO 2025 #USA #Orlando #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma Set to Showcase Innovative LACRIFILL Gel at 2025 AAO Conference At the 2025 American Academy of Ophthalmology conference, Nordic Pharma will present its groundbreaking LACRIFILL gel for dry eye treatment, sharing patient insights and treatment efficacy.

Nordic Pharma Set to Showcase Innovative LACRIFILL Gel at 2025 AAO Conference #USA #Orlando,_Florida #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma to Showcase LACRIFILL Canalicular Gel at AAO 2025 in Orlando Nordic Pharma will present its LACRIFILL Canalicular Gel at the AAO 2025 meeting, highlighting patient data that showcases its effectiveness for dry eye treatment.

Nordic Pharma to Showcase LACRIFILL Canalicular Gel at AAO 2025 in Orlando #USA #Orlando #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma to Showcase Innovative LacriFill Gel at AAO 2025 Nordic Pharma will present LacriFill Canalicular Gel, a groundbreaking treatment for dry eye symptoms, at the 2025 AAO annual meeting in Orlando.

Nordic Pharma to Showcase Innovative LacriFill Gel at AAO 2025 #USA #Orlando #Nordic_Pharma #LACRIFILL #Dry_Eye_Gel

Nordic Pharma's Innovative Lacrifill Gel Featured in DEWS III Report Recognizing Advances in Dry Eye Management Nordic Pharma's Lacrifill Canalicular Gel is now included in the latest DEWS III report, affirming its effectiveness in treating dry eye symptoms.

Nordic Pharma's Innovative Lacrifill Gel Featured in DEWS III Report Recognizing Advances in Dry Eye Management #USA #Berwyn #Nordic_Pharma #LACRIFILL #DEWS_III

Nordic Pharma's Lacrifill Canalicular Gel Introduced in Major Dry Eye Report Nordic Pharma, a subsidiary of Nordic Group B.V., announces Lacrifill Canalicular Gel's inclusion in a vital report on dry eye management and therapy.

Nordic Pharma's Lacrifill Canalicular Gel Introduced in Major Dry Eye Report #USA #Berwyn #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma Introduces LACRIFILL Canalicular Gel in DEWS III Report for Dry Eye Management Nordic Pharma's LACRIFILL Canalicular Gel has been included in the DEWS III report as a major advancement in treating dry eye symptoms. Learn more about its efficacy.

Nordic Pharma Introduces LACRIFILL Canalicular Gel in DEWS III Report for Dry Eye Management #USA #Berwyn #Nordic_Pharma #LACRIFILL #Dry_Eyes

Nordic Pharma to Present Breakthrough Dry Eye Therapy at ASCRS Annual Meeting Nordic Pharma will showcase a new dry eye therapy, Lacrifill® Canalicular Gel, during the ASCRS Annual Meeting, highlighting patient data and experience.

Nordic Pharma to Present Breakthrough Dry Eye Therapy at ASCRS Annual Meeting #USA #Los_Angeles #Nordic_Pharma #LACRIFILL #ASCRS

Insights into LACRIFILL® Canalicular Gel for Dry Eye Treatment from Nordic Pharma at ASCRS Annual Meeting Nordic Pharma shares groundbreaking patient data and experiences regarding LACRIFILL® Canalicular Gel, offering new hope for dry eye treatment during ASCRS 2025.

Insights into LACRIFILL® Canalicular Gel for Dry Eye Treatment from Nordic Pharma at ASCRS Annual Meeting #USA #Los_Angeles #Nordic_Pharma #LACRIFILL #Dry_Eyes

Nordic Pharma Reveals New Dry Eye Treatment at ASCRS Annual Meeting Nordic Pharma, Inc. presents significant findings on LACRIFILL® Canalicular Gel for dry eye relief at the ASCRS Annual Meeting in Los Angeles, demonstrating a promising path forward.

Nordic Pharma Reveals New Dry Eye Treatment at ASCRS Annual Meeting #United_States #Los_Angeles #Nordic_Pharma #LACRIFILL #Dry_Eye

Nordic Pharma Showcases Patient Insights for LACRIFILL® Gel at ASCRS 2025 Nordic Pharma, Inc. is set to present its latest findings on LACRIFILL® Canalicular Gel for dry eye treatment at the ASCRS Annual Meeting, highlighting patient experience and outcomes.

Nordic Pharma Showcases Patient Insights for LACRIFILL® Gel at ASCRS 2025 #USA #Los_Angeles #Nordic_Pharma #LACRIFILL #dry_eye_therapy

Nordic Pharma Unveils Details of LACRIFILL® Poster Presentation at SECO 2025 Nordic Pharma, Inc. announces a poster presentation for LACRIFILL® Canalicular Gel at SECO 2025 in Atlanta, shedding light on innovative treatments for dry eye disease.

Nordic Pharma Unveils Details of LACRIFILL® Poster Presentation at SECO 2025 #USA #Atlanta #Eye_Care #Nordic_Pharma #LACRIFILL

Nordic Pharma to Showcase Innovative Lacrimal Gel at SECO 2025 Conference Nordic Pharma, Inc. announces a poster presentation of Lacrimal Occlusion Case Series at SECO 2025, highlighting advances in dry eye treatment.

Nordic Pharma to Showcase Innovative Lacrimal Gel at SECO 2025 Conference #USA #Atlanta #Nordic_Pharma #LACRIFILL #SECO_2025

Nordic Pharma to Present Innovative LACRIFILL Gel at SECO 2025 Conference Discover the pioneering LACRIFILL Canalicular Gel from Nordic Pharma, showcased at SECO 2025 for its revolutionary impact on dry eye treatment.

Nordic Pharma to Present Innovative LACRIFILL Gel at SECO 2025 Conference #USA #Atlanta #Nordic_Pharma #LACRIFILL #SECO_2025